Skip to main content

William Sharp, Steven Stice

Premium
Aruna Biomedical announced this week that William Sharp has been named president and chief executive officer. Sharp has also been appointed to Aruna's board of directors. He succeeds Aruna founder Steven Stice,who will remain Aruna's chairman and chief scientific officer. 
 

Sharp most recently served as chief commercial officer of BioProcessors, a venture-financed life science tools developer based near Boston, Mass. Prior to BioProcessors, he was senior vice president of business development at Cellomics, vice president of business development at Gentra Systems, worldwide director for the molecular biology business of Life Technologies (now Invitrogen), and vice president of sales and marketing at Heraeus Instruments

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.